openPR Logo
Press release

Global Peripheral Neuropathy Treatment Market 2020 Size, Growth Analysis Report, Forecast to 2026

12-23-2020 07:50 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

The global peripheral neuropathy treatment market is estimated to grow at a CAGR of 4.3% during the forecast period. A significant rise in diabetes prevalence is the major factor in accelerating market growth. As per the International Diabetes Federation (IDF), in 2019, nearly 463 million adults (20-79 years) were suffering from diabetes, which is expected to reach 700 million by 2045. Uncontrolled high blood sugar can damage nerves and impede nerves' ability to transmit signals, which results in diabetic neuropathy. High blood sugar also impairs the walls of the capillaries (small blood vessels) that deliver the nerves with nutrients and oxygen. Peripheral neuropathy is a common type of diabetic neuropathy, which firstly affects the legs and feet, followed by the arms and hands.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/peripheral-neuropathy-treatment-market

It is a severe diabetic complication that may affect nearly 50% of people suffering from diabetes. This, in turn, is contributing to the demand for peripheral neuropathy treatment. The most commonly used drugs for the condition include anti-seizure drugs, antidepressants, and pain-relievers. Anti-seizure medications include pregabalin (Lyrica) and gabapentin (Gralise, Neurontin). Some antidepressants are used to ease nerve pain, even the patient is not depressed. Tricyclic antidepressants may provide relied on mild to moderate nerve pain. Drugs used for this class include desipramine (Norpramin), imipramine (Tofranil), and amitriptyline.

A Full Report of Global Peripheral Neuropathy Treatment Market is Available at: https://www.omrglobal.com/industry-reports/peripheral-neuropathy-treatment-market

Scope of the Global Peripheral Neuropathy Treatment Market

Market Coverage

The market number available for 2019-2026
Base year- 2019
Forecast period- 2020-2026
Segment Covered- By Type and Application
Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World
Competitive Landscape- Pfizer Inc., Grünenthal GmbH, Novartis International AG, Eli Lilly and Co., and Daiichi Sankyo Co. Ltd.

Global Peripheral Neuropathy Treatment Market-Segmentation

By Type

Antidepressants
Pain Relievers
Antiseizure
Others

By Application

Diabetes
Chemotherapy-Induced
Others

Global Peripheral Neuropathy Treatment Market– Segment by Region

North America

US
Canada

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Latin America
Middle East and Africa

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/peripheral-neuropathy-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peripheral Neuropathy Treatment Market 2020 Size, Growth Analysis Report, Forecast to 2026 here

News-ID: 2216194 • Views:

More Releases from Orion Market Research

Healthcare Distribution Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Healthcare Distribution Market Size, Trends, Latest Insights, Analysis and Forec …
Global healthcare distribution market is anticipated to grow at a CAGR of 6.7% during the forecast period (2024-2031). Globally, a considerable increase in the burden of chronic diseases pressuring countries to adopt effective and efficient distribution of healthcare products. Commonly prevailing chronic diseases include heart attacks and strokes, cancer such as breast and colon, diabetes, epilepsy and seizures, obesity, and oral health issues. To learn more about this report request
Prediabetes Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Prediabetes Market Size, Trends, Latest Insights, Analysis and Forecast 2024-203 …
Global prediabetes market is anticipated to grow at a CAGR of 7.2% during the forecast period (2024-2031). A major factor supporting the growth of the market is the increasing product expansion and new drugs in the market. For instance, in January 2024, Novo Nordisk announced the launch of its Wegovy, a GLP-1 analog in the UK. This drug can be prescribed to people with prediabetes and for weight loss purposes.
Rapid Test Market Increasing Demand, Growth Analysis and Future Outlook by 2031
Rapid Test Market Increasing Demand, Growth Analysis and Future Outlook by 2031
The global rapid test market is anticipated to grow at a considerable CAGR of 8.2% during the forecast period (2024-2031). The increasing government initiatives for diagnosing infectious diseases owing to the growing prevalence of infectious diseases and the key developments by the market players. In order to monitor the infection rate of specific pathogens, infection monitoring and surveillance programs have grown over the past few several years. Rapid diagnostic
AI in Patient Engagement Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
AI in Patient Engagement Market Size, Trends, Latest Insights, Analysis and Fore …
Global AI in patient engagement market is anticipated to grow at a CAGR of 21.0 % during the forecast period (2024-2031). AI-powered communication tools support patients by addressing their inquiries, scheduling appointments, and providing information about their health conditions and treatments. These tools enhance patient engagement, improve access to healthcare information, and streamline administrative processes for healthcare providers. Furthermore, AI algorithms analyze large datasets, including electronic health records (EHRs), medical

All 5 Releases


More Releases for Peripheral

PC Gaming Peripheral Market
PC Gaming Peripheral Market Research study which offers insights of in-depth research on historic and current market size along with the expected future prospects of the market and emerging trends in the market. The PC Gaming Peripheral Market report provides crucial information about the market, including Opinions from Industry experts, and the recent progressions and developments of the PC Gaming Peripheral Market. PC gaming peripheral are external hardware devices such as
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera …
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorder
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip …
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack. Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533 The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a
Peripheral Intravenous Catheter Market
New research report offers a comprehensive analysis of the “Peripheral Intravenous Catheter Market: Asia Pacific Regional Market to Witness the Fastest Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2021“The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market. Request to view Sample Report @ https://www.mrrse.com/sample/2827 Peripheral intravenous catheter is a sophisticated medical device widely used to
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline …
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Peripheral Arterial Disease (PAD) Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Peripheral Arterial Disease (PAD) Peripheral Vascular Disease (PVD) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics,